Back to results
US 2024/0174734 A1Published application
Parvovirus antibody
AssigneeYntoAb Co., Ltd.
InventorsSung Young LEE, Na Ra Shin
Life of this patent
Estimating the term…
Abstract
Antibodies that bind parvovirus are disclosed. The antibodies can be used in methods for preventing or treating parvovirus infection.
Claims12
An isolated antibody that binds to parvovirus, wherein the antibody comprises:
- a) a CDR-H1 comprising the amino acid sequence of SEQ ID NO:
- 14, a CDR-H2 comprising the amino acid sequence of SEQ ID NO:
- 16, a CDR-H3 comprising the amino acid sequence of SEQ ID NO:
- 18, and a CDR-L1 comprising the amino acid sequence of SEQ ID NO:
- 22, a CDR-L2 comprising the amino acid sequence of SEQ ID NO:
- 24, a CDR-L3 comprising the amino acid sequence of SEQ ID NO:
- 26, or
- b) a CDR-H1 comprising the amino acid sequence of SEQ ID NO:
- 30, a CDR-H2 comprising the amino acid sequence of SEQ ID NO:
- 32, a CDR-H3 comprising the amino acid sequence of SEQ ID NO:
- 34, and a CDR-L1 comprising the amino acid sequence of SEQ ID NO:
- 38, a CDR-L2 comprising the amino acid sequence of SEQ ID NO:
- 40, a CDR-L3 comprising the amino acid sequence of SEQ ID NO:
- 42.
11 more elements
A method of treating a canine parvoviral infection in a subject comprising administering to the subject a therapeutically effective amount of antibody that binds to the parvovirus.
Dependencies are inferred from the claim text.